{
    "2018-09-05": [
        [
            {
                "time": "2018-09-06",
                "original_text": "Shire plc (SHPG) Ex-Dividend Date Scheduled for September 06, 2018",
                "features": {
                    "keywords": [
                        "Shire plc",
                        "Ex-Dividend Date",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "J&J Submits NDA to the FDA for Depression Drug in Adults",
                "features": {
                    "keywords": [
                        "J&J",
                        "NDA",
                        "FDA",
                        "Depression Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "How Abiomed’s Revenue Trended in the First Quarter",
                "features": {
                    "keywords": [
                        "Abiomed",
                        "Revenue",
                        "Trended",
                        "First Quarter"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "medical devices"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-01",
                "original_text": "Analyzing Alexion Pharmaceuticals’ Operational Performance",
                "features": {
                    "keywords": [
                        "Alexion Pharmaceuticals",
                        "Operational Performance"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-01",
                "original_text": "Alexion’s Top Line Continues to Expand Significantly",
                "features": {
                    "keywords": [
                        "Alexion",
                        "Top Line",
                        "Expand",
                        "Significantly"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-01",
                "original_text": "3 Biotech Stocks That Still Have Major Catalysts in September",
                "features": {
                    "keywords": [
                        "Biotech Stocks",
                        "Major Catalysts",
                        "September"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}